Medicare Enrolled

Dr. Andrew Nguyen, MD

Urology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2750 W BROADWAY, Los Angeles, CA 90041
8182413125
In practice since 2007 (19 years)
NPI: 1821147224 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nguyen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nguyen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nguyen

Dr. Andrew Nguyen is an urology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nguyen performed 5,996 Medicare services across 3,887 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nguyen received a total of $12,686 from 42 pharmaceutical and/or device companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nguyen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in CA $12,686 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,996
Medicare services
Top 17% in CA for urology physician
3,887
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~316 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
1,110 $4 $10
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
1,056 $9 $45
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
616 $71 $161
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
532 $11 $75
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
465 $100 $238
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
313 $51 $130
Ultrasound of abdomen and pelvis blood flow
An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis.
292 $121 $376
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
275 $100 $226
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
192 $93 $250
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
174 $48 $92
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
129 $126 $362
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
125 $212 $459
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
116 $44 $106
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
108 $145 $439
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
104 $64 $187
Simple measurement of urine flow pressure in bladder
A test that measures the pressure of urine flow within the bladder. This procedure assesses bladder function by recording pressure changes during urination.
92 $104 $426
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
69 $48 $98
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
54 $74 $239
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
33 $123 $214
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
28 $54 $165
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
25 $20 $40
Ureteral stent insertion via cystoscopy
A tube is placed into the ureter using an endoscope inserted through the bladder.
19 $41 $600
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
17 $89 $1,117
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
15 $52 $135
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
14 $201 $485
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
12 $286 $544
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
11 $90 $1,577
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
34.3% medium
64.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,686
Total received (2018-2024)
Avg $1,812/year across 7 years
Top 16% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
327
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,127 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$559 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,718
2023
$3,791
2022
$674
2021
$1,132
2020
$1,074
2019
$1,525
2018
$2,773

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BLUEWIND MEDICAL
$690
Sumitomo Pharma America, Inc.
$233
PFIZER INC.
$179
ACCORD HEALTHCARE, INC.
$160
Astellas Pharma US Inc
$73
Myriad Genetic Laboratories, Inc.
$67
Teleflex LLC
$58
UROGEN PHARMA, INC.
$55
ABBVIE INC.
$47
Ethicon US, LLC
$36
Boston Scientific Corporation
$34
PROCEPT BioRobotics Corporation
$34
Merck Sharp & Dohme LLC
$30
Tolmar, Inc.
$22
Top 3 companies account for 64.1% of 2024 payments
All-time payments by company (2018-2024) ›
PROCEPT BioRobotics Corporation
$2,582
NeoTract Inc.
$2,235
Astellas Pharma US Inc
$1,391
Boston Scientific Corporation
$1,104
PFIZER INC.
$887
BLUEWIND MEDICAL
$690
Axonics, Inc.
$647
Teleflex LLC
$411
Sumitomo Pharma America, Inc.
$262
Myriad Genetic Laboratories, Inc.
$253
Celgene Corporation
$252
ACCORD HEALTHCARE, INC.
$160
Coloplast Corp
$159
Intuitive Surgical, Inc.
$147
Medtronic, Inc.
$146
AbbVie Inc.
$138
COLOPLAST CORP
$129
UROVANT SCIENCES INC
$95
TherapeuticsMD, Inc.
$92
Tolmar, Inc.
$90
TOLMAR Pharmaceuticals, Inc.
$85
ABBVIE INC.
$76
UroGen Pharma, Inc.
$68
Ethicon US, LLC
$64
UROGEN PHARMA, INC.
$55
180 Medical, Inc.
$52
Blue Earth Diagnostics Limited
$51
BOSTON SCIENTIFIC CORPORATION
$51
Duchesnay USA Incorporated
$49
Avadel Specialty Pharmaceuticals, LLC
$36
Merck Sharp & Dohme LLC
$30
Otsuka America Pharmaceutical, Inc.
$23
PRN Medical Services, LLC
$23
Olympus America Inc.
$20
Sagent Pharmaceuticals, Inc.
$20
Amgen Inc.
$19
Endo Pharmaceuticals Inc.
$19
Metuchen Pharmaceuticals
$18
MEDIVATION FIELD SOLUTIONS LLC
$16
AKRIMAX PHARMACEUTICALS, LLC
$16
Mission Pharmacal Company
$13
AbbVie, Inc.
$11
Top 3 companies account for 48.9% of all-time payments
Associated products mentioned in payments ›
ALTIS · AMS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Altis · Axonics · Axumin · BOTOX · Bulkamid · Da Vinci Surgical System · ELIGARD · Echelon Flex · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · Glydo · HARMONIC Product Family · IMVEXXY · INTELLIS · JATENZO · JELMYTO · JYNARQUE · LUPRON DEPOT · LYNPARZA · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · OBTRYX · Olympus Cysto-Resection · Osphena · Otezla · PREMARIN · PROLARIS · Porges Coloplast · Prolaris · Prolia · REVI · REZUM · Rezum Generator · Solyx SIS System · SpeediCath · Stendra · TOVIAZ · UROLIFT · Uribel · UroLift · UroLift System · VRAYLAR · Veozah · XIAFLEX · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Los Angeles?
Compare urology physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
402
Per 100K population
4.1
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nguyen is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nguyen experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Nguyen performed 1,110 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nguyen receive payments from pharmaceutical companies?
Yes. Dr. Nguyen received a total of $12,686 from 42 companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nguyen's costs compare to other urology physicians in Los Angeles?
Dr. Nguyen's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nguyen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →